Ronald Leroy JR Langham
CIK 1966567 · EVP Clinical Excel. & Strategy · last filed 2025-03-10
Ronald Leroy JR Langham is an EVP Clinical Excel. & Strategy who has filed 11 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for EHAB, was dated Mar 10, 2025. Across all open-market trades the lifetime net is +$114.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $807.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$807.9K
1
11
$114.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EHAB | EVP Clinical Excel. & Strategy | 58,541 | $13.80 | $807.9K | $114.3K | 11 | 2025-03-10 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-10 | EHAB | Mixed | +4,715 | $37.8K | EDGAR |
| 2025-03-04 | EHAB | Tax (F) | −3,041 | -$25.5K | EDGAR |
| 2025-02-26 | EHAB | Tax (F) | −334 | -$2.8K | EDGAR |
| 2025-01-03 | EHAB | Tax (F) | −1,687 | -$13.2K | EDGAR |
| 2024-07-03 | EHAB | Tax (F) | −673 | -$5.9K | EDGAR |
| 2024-03-05 | EHAB | Mixed | +14,393 | $126.8K | EDGAR |
| 2024-02-27 | EHAB | Tax (F) | −514 | -$4.9K | EDGAR |
| 2024-01-03 | EHAB | Tax (F) | −1,043 | -$10.8K | EDGAR |
| 2023-05-22 | EHAB | Buy (P) | +10,000 | $119.9K | EDGAR |
| 2023-03-03 | EHAB | Grant (A) | +8,763 | $0 | EDGAR |